| 1 | 1306118 | Caffeine as a probe for human cytochromes P450: validation using cDNA-expression, immunoinhibition and microsomal kinetic and inhibitor techniques. | Pharmacogenetics | 1992 Aug |
1 |
| 2 | 8095225 | Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Evidence from cDNA-directed expression in Saccharomyces cerevisiae. | Drug Metab Dispos | 1993 Jan-Feb |
2 |
| 3 | 9868741 | Fluvoxamine is a potent inhibitor of the metabolism of caffeine in vitro. | Pharmacol Toxicol | 1998 Dec |
2 |
| 4 | 10076532 | Strain differences in CYP3A-mediated C-8 hydroxylation (1,3,7-trimethyluric acid formation) of caffeine in Wistar and Dark Agouti rats. Rapid metabolism of caffeine in debrisoquine poor metabolizer model rats. | Biochem Pharmacol | 1998 May 1 |
1 |
| 5 | 11985335 | Effects of phenothiazine neuroleptics on the rate of caffeine demethylation and hydroxylation in the rat liver. | Pol J Pharmacol | 2001 Nov-Dec |
1 |
| 6 | 12110375 | Differences in caffeine and paraxanthine metabolism between human and murine CYP1A2. | Biochem Pharmacol | 2002 Jun 15 |
1 |
| 7 | 26967371 | Role of Enzyme Flexibility in Ligand Access and Egress to Active Site: Bias-Exchange Metadynamics Study of 1,3,7-Trimethyluric Acid in Cytochrome P450 3A4. | J Chem Theory Comput | 2016 Apr 12 |
1 |
| 8 | 31123759 | Identification of the caffeine to trimethyluric acid ratio as a dietary biomarker to characterise variability in cytochrome P450 3A activity. | Eur J Clin Pharmacol | 2019 Sep |
1 |